CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

MLA

Skoulidis, Ferdinandos, et al. “CTLA4 Blockade Abrogates KEAP1/STK11-Related Resistance to PD-(L)1 Inhibitors.” Nature, vol. 635, no. 8038, Nov. 2024, pp. 462–71. EBSCOhost, https://doi.org/10.1038/s41586-024-07943-7.

APA

Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Cobo, A. G., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., Juan, J. M., Min, C., Yu, Y., Pan, X., Arbour, K. C., Vokes, N., Schmidt, S. T., Molkentine, D., Owen, D. H., … Heymach, J. V. (2024). CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature, 635(8038), 462–471. https://doi.org/10.1038/s41586-024-07943-7

Chicago

Skoulidis, Ferdinandos, Haniel A. Araujo, Minh Truong Do, Yu Qian, Xin Sun, Ana Galan Cobo, John T. Le, et al. 2024. “CTLA4 Blockade Abrogates KEAP1/STK11-Related Resistance to PD-(L)1 Inhibitors.” Nature 635 (8038): 462–71. doi:10.1038/s41586-024-07943-7.